# The Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2024, Regulation 36: Amendment to regulation 58


In regulation 58 (detailed guidance), in paragraph (c), for “substantial amendment to the clinical trial authorisation” substitute “substantial modification, as defined in regulation 11 (interpretation of Part 3),”.

---
Source: https://www.legislation.gov.uk/ukdsi/2024/9780348267167/regulation/36 (the official version)
Page: https://openlegislation.uk/draft-medicines-for-human-use-clinical-trials-amendment-regulations-2024/regulation-36
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.